Clinical Trial Update: Neoadjuvant Tebentafusp for Uveal Melanoma [Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 2 neoadjuvant trial of tebentafusp for locally advanced unresectable uveal melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• KIMMTRAK (tebentafusp)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Locally Advanced Unresectable Uveal Melanoma | Phase 2 | Status: RECRUITING